Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...
Worse, the most recent CERN implementation of the FPGA-Based Level-1 Trigger planned for the 2026-2036 decade is a 650 kW system containing an incredibly high number of transistor, 20 trillion in all, ...
Q1 2026 Earnings Call Transcript December 18, 2025 FactSet Research Systems Inc. beats earnings expectations. Reported EPS is $4.51, expectations were $4.36. Operator: Good day. Thank you for standing ...
Navigators on racing yachts face complex challenges that go well beyond plotting a course. Their idol is a man known ...
(11/15 participants) improved on the Overall Cutaneous Venous Malformations Investigator Global Assessment (Overall ...
ALT shares drop over 20% after updated pemvidutide week 48 data; see FDA's stance on non-invasive fibrosis tests. Click here ...
Want board approval for tech? Stop pitching IT and start telling a business story about value, risk, ROI and where the ...
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...
When TGL presented by SoFi returns on December 28, the innovative indoor golf league will debut a series of enhancements ...
Q4 2025 Earnings Call Transcript December 11, 2025 Ciena Corporation beats earnings expectations. Reported EPS is $0.91, ...
Presenting your user experience (UX) work is not just a meeting on the calendar; it is a skill that can either save or ruin a project. It is at this point that ...
Explore This SectionEarthEarth ObserverEditor's CornerFeature ArticlesMeeting SummariesNewsScience in the NewsCalendarsIn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback